COVID-19 AND CANCER COMORBIDITY: THERAPEUTIC OPPORTUNITIES AND CHALLENGES (RUSSIAN TRANSLATION)
The coronavirus disease 2019 (COVID-19) is a viral disease caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the respiratory system of infected individuals. COVID-19 spreads between humans through respiratory droplets produced when an infected person coughs...
Main Authors: | A. S. Pathania, P. Prathipati, B. A. A. Abdul, S. Chava, S. S. Katta, S. C. Gupta, P. R. Gangula, M. K. Pandey, D. L. Durden, S. N. Byrareddy, K. B. Challagundla |
---|---|
Format: | Article |
Language: | English |
Published: |
Scientia Publishing House
2021-12-01
|
Series: | Juvenis Scientia |
Subjects: | |
Online Access: | https://jscientia.org/index.php/js/user/setLocale/en_US?source=/index.php/js/article/view/133?utm_source=DOAJ |
Similar Items
-
Charlson comorbidity index in predicting deaths in COVID-19 patients
by: A. V. Svarovskaya, et al.
Published: (2022-04-01) -
Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis
by: Boyan K. Tsankov, et al.
Published: (2021-02-01) -
Clinico-demographic, hematological, and comorbidity profile of COVID-19 patients admitted at tertiary care center
by: Hemant Kumar, et al.
Published: (2021-01-01) -
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma
by: Venugopal Gunda, et al.
Published: (2020-09-01) -
A comparative study of the course and outcome in hypoxic COVID-19 patients with and without comorbidities
by: Shreyas Deepak Wajekar, et al.
Published: (2022-01-01)